Recombinant Human TNFb Protein，His

Tumor Necrosis Factor beta (TNFb), also known as Lymphotoxin-alpha, is a cytokine that plays a crucial role in immune regulation and inflammation. It is primarily produced by activated T and Natural Killer (NK) cells and is known for its ability to induce cell apoptosis, promote cell proliferation, and modulate immune responses. The functional diversity of TNFb has garnered significant attention in the fields of immunology and cancer research, as it is involved in various pathological and physiological processes. The exploration of recombinant TNFb proteins is essential for understanding its molecular mechanisms and biological activities. By producing TNFb in recombinant systems, researchers can gain insights into its structure-function relationship, effects on various cell types, and potential therapeutic applications. Furthermore, studying TNFb in a recombinant form enables the development of targeted therapies for autoimmune diseases and cancer, paving the way for treatments that can manipulate TNFb signaling pathways. The advancements in recombinant DNA technology have made it possible to produce large quantities of TNFb, facilitating detailed studies into its role in tumorigenesis and chronic inflammation. This research not only enhances our understanding of TNFb's biological functions but also helps in the identification of biomarkers for disease and potential drug targets, contributing to the development of innovative therapeutic approaches.